{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:12:54Z","timestamp":1793866374292,"version":"4.6.1"},"reference-count":107,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) is a frequent and serious cardiovascular complication in oncology patients, driven by shared pathophysiological mechanisms of inflammation, thrombosis, and cardiac remodeling. Cancer and its therapies significantly increase AF risk, impacting survival, quality of life, and management complexity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This narrative review synthesizes current evidence on the epidemiology, pathogenesis, and management of AF in cancer, emphasizing inflammatory and prothrombotic pathways, treatment-related cardiotoxicity, and cardio-oncology strategies. Literature was retrieved from PubMed and recent cardio-oncology guidelines to provide an integrated overview of mechanistic insights and therapeutic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cancer patients exhibit up to a 10-fold higher risk of AF than the general population, particularly with esophageal, lung, and hematologic malignancies. Mechanistically, the NLRP3 inflammasome, neutrophil extracellular traps, and hypercoagulability promote atrial fibrosis and electrical instability. Cancer therapies\u2014including anthracyclines, platinum agents, tyrosine kinase inhibitors, immunotherapies, and thoracic radiation\u2014further potentiate AF. Management is challenging due to drug\u2013drug interactions, bleeding risks, and altered pharmacokinetics. Evidence supports the use of direct oral anticoagulants when feasible and emphasizes multidisciplinary cardio-oncology collaboration. Personalized anticoagulation, vigilant rhythm monitoring, and shared decision-making are key to optimizing outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AF in cancer arises from a convergence of inflammation, thrombosis, and therapy-induced injury. A structured, multidisciplinary cardio-oncology approach integrating early risk stratification, tailored anticoagulation, and preventive strategies is essential. Future research should focus on oncology-specific risk prediction tools, biomarker-guided management, and randomized trials to refine evidence-based care for this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10760296251408388","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:15:40Z","timestamp":1765995340000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancer, Inflammation, and Thrombosis: Drivers of Atrial Fibrillation in Oncology Patients"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5122-8200","authenticated-orcid":false,"given":"Ameer","family":"Awashra","sequence":"first","affiliation":[{"name":"An Najah National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6089-240X","authenticated-orcid":false,"given":"Hamza A.","family":"Abdul-Hafez","sequence":"additional","affiliation":[{"name":"An Najah National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaath","family":"Swalha","sequence":"additional","affiliation":[{"name":"An Najah National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Samara","sequence":"additional","affiliation":[{"name":"An Najah National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Mahafdah","sequence":"additional","affiliation":[{"name":"Yarmouk University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"AbuBaha","sequence":"additional","affiliation":[{"name":"An Najah National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2718-8627","authenticated-orcid":false,"given":"Ahmed","family":"Emara","sequence":"additional","affiliation":[{"name":"Al-Azhar University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Zahran","sequence":"additional","affiliation":[{"name":"An Najah National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Elgendy","sequence":"additional","affiliation":[{"name":"Tanta University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalhakim","family":"Shubietah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"1","key":"e_1_3_3_2_2","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar JA","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2024 Jan 2 [cited 2025 Sep 8];149(1), Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation [Internet]"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6314-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2022.100026"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-025-02261-4"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1506143"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e23324"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.100991"},{"issue":"0","key":"e_1_3_3_9_2","article-title":"The gut-heart axis in atrial fibrillation: Pathophysiology, evidence, and therapeutic potential","volume":"0","author":"Awashra A","unstructured":"Awashra A, Neiroukh H, AbuBaha M, et al. The gut-heart axis in atrial fibrillation: Pathophysiology, evidence, and therapeutic potential. Heart Rhythm O2 [Internet]. 2025 Oct 31 [cited 2025 Nov 13];0(0), Available from: https:\/\/www.heartrhythmopen.com\/article\/S2666-5018(25)00523-9\/fulltext.","journal-title":"Heart Rhythm O2 [Internet]"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04259-9"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2023.04.301"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000932"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/life14050621"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.08.011"},{"issue":"1","key":"e_1_3_3_15_2","first-page":"48","article-title":"Crosslink between atrial fibrillation and cancer: A therapeutic conundrum","volume":"10","author":"Nardi E","unstructured":"Nardi E, Santoro C, Prastaro M, et al. Crosslink between atrial fibrillation and cancer: A therapeutic conundrum. Cardio-Oncol. 2024 Aug 7;10(1):48.","journal-title":"Cardio-Oncol"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-019-0885-z"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037948"},{"key":"e_1_3_3_18_2","unstructured":"Guo Q Du X Ma CS. Atrial fibrillation and frailty."},{"key":"e_1_3_3_19_2","article-title":"Atrial fibrillation and cancer","volume":"8","author":"Hajjar LA","unstructured":"Hajjar LA, Fonseca SMR, Machado TIV. Atrial fibrillation and cancer. Front Cardiovasc Med [Internet]. 2021 Jul 15 [cited 2025 Sep 8];8, Available from: https:\/\/www.frontiersin.org\/journals\/cardiovascular-medicine\/articles\/10.3389\/fcvm.2021.590768\/full.","journal-title":"Front Cardiovasc Med [Internet]"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.026"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.00024.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.2"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00886-5"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.03.379"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa345"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2025.02.011"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035202"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.001"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00062.2021"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01497-2"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112550"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13952"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000986"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.059"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38831"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4246.4246"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw119"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.11838"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001182"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.07.016"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.04.009"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1441-7"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0392-z"},{"issue":"1","key":"e_1_3_3_45_2","first-page":"2","article-title":"Management of atrial fibrillation in patients taking targeted cancer therapies","volume":"3","author":"Asnani A","unstructured":"Asnani A, Manning A, Mansour M, Ruskin J, Hochberg EP, Ptaszek LM. Management of atrial fibrillation in patients taking targeted cancer therapies. Cardio-Oncol. 2017 Mar 9;3(1):2.","journal-title":"Cardio-Oncol"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0047-5"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.04.012"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.3635"},{"key":"e_1_3_3_49_2","article-title":"Cancer radiation therapy may be associated with atrial fibrillation","volume":"8","author":"Apte N","unstructured":"Apte N, Dherange P, Mustafa U, et al. Cancer radiation therapy may be associated with atrial fibrillation. Front Cardiovasc Med [Internet]. 2021 Jan 22 [cited 2025 Sep 8];8, Available from: https:\/\/www.frontiersin.org\/journals\/cardiovascular-medicine\/articles\/10.3389\/fcvm.2021.610915\/full.","journal-title":"Front Cardiovasc Med [Internet]"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12690-y"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1467"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-7-4"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2022.12.016"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2024.06.005"},{"issue":"1","key":"e_1_3_3_55_2","first-page":"29","article-title":"Atrial fibrillation in cancer survivors \u2013 a systematic review and meta-analysis","volume":"9","author":"Bao Y","unstructured":"Bao Y, Lee J, Thakur U, Ramkumar S, Marwick TH. Atrial fibrillation in cancer survivors \u2013 a systematic review and meta-analysis. Cardio-Oncol. 2023 Jun 17;9(1):29.","journal-title":"Cardio-Oncol"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2022.13125"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14241"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht024"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.4103\/jcecho.jcecho_8_19"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001174"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeae053"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100609"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.09.008"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13244"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092574"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38071-3"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004012"},{"issue":"15","key":"e_1_3_3_68_2","article-title":"Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association","volume":"145","author":"Beavers CJ","unstructured":"Beavers CJ, Rodgers JE, Bagnola AJ, et al. Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2022 Apr 12 [cited 2025 Sep 8];145(15), Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001056.","journal-title":"Circulation [Internet]"},{"key":"e_1_3_3_69_2","article-title":"Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect","volume":"200","author":"Tamargo J","unstructured":"Tamargo J, Villacast\u00edn J, Caballero R, Delp\u00f3n E. Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect. Pharmacol Res. 2024 Feb;200:107077.","journal-title":"Pharmacol Res"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051318"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12055-020-00935-y"},{"issue":"10","key":"e_1_3_3_72_2","article-title":"Outcome of atrial fibrillation ablation in cancer patients: A review","volume":"15","author":"Sharma NR","unstructured":"Sharma NR, Basnet A, Lamichhane S, et al. Outcome of atrial fibrillation ablation in cancer patients: A review. Cureus. 2023 Oct;15(10):e47818.","journal-title":"Cureus"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081331"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2021.01.011"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2022.63"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5400"},{"key":"e_1_3_3_77_2","unstructured":"The cardio-oncology multidisciplinary team: beyond the basics | Cardio-Oncology | Full Text [Internet]. [cited 2025 Nov 13]. Available from: https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-025-00369-8"},{"key":"e_1_3_3_78_2","unstructured":"What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist? \u2013 PubMed [Internet]. [cited 2025 Nov 13]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33832839\/"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2023.09.002"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S377697"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.028"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.002"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817591"},{"key":"e_1_3_3_84_2","unstructured":"American College of Cardiology [Internet]. [cited 2025 Nov 13]. Smartwatches and Atrial Fibrillation: What Works and What Needs Improvement? Available from: https:\/\/www.acc.org\/Latest-in-Cardiology\/Articles\/2024\/05\/29\/16\/56\/http%3a%2f%2fwww.acc.org%2fLatest-in-Cardiology%2fArticles%2f2024%2f05%2f29%2f16%2f56%2fSmartwatches-and-Atrial-Fibrillation."},{"key":"e_1_3_3_85_2","unstructured":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet | New England Journal of Medicine [Internet]. [cited 2025 Nov 13]. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1200303"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-020-02346-6"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101869"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26528"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061260"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092059"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.08.030"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028562"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049210"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108926"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.04.008"},{"key":"e_1_3_3_96_2","unstructured":"Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation | Nature Communications [Internet]. [cited 2025 Nov 13]. Available from: https:\/\/www.nature.com\/articles\/s41467-025-62218-7"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-023-02968-x"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247753"},{"issue":"5","key":"e_1_3_3_99_2","first-page":"344","article-title":"Bleeding and embolic risk in patients with atrial fibrillation and cancer","volume":"76","author":"Raposeiras-Roub\u00edn S","unstructured":"Raposeiras-Roub\u00edn S, Abu-Assi E, Fern\u00e1ndez Sanz T, et al. Bleeding and embolic risk in patients with atrial fibrillation and cancer. Rev Espanola Cardiol Engl Ed. 2023 May;76(5):344\u2013352.","journal-title":"Rev Espanola Cardiol Engl Ed"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.06.044"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2022.08.014"},{"key":"e_1_3_3_102_2","unstructured":"CHA2DS2-VASc Score in Cardio-Oncology: Sharpening the Rules\u2217 | JACC: CardioOncology [Internet]. [cited 2025 Nov 13]. Available from: https:\/\/www.jacc.org\/doi\/10.1016\/j.jaccao.2023.01.007"},{"issue":"10","key":"e_1_3_3_103_2","first-page":"1612","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel J","unstructured":"Steffel J, Collins R, Antz M, et al. 2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2021 Oct 9;23(10):1612\u20131676.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.09.011"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14293"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000750"},{"issue":"9","key":"e_1_3_3_107_2","article-title":"Outcomes and readmissions in patients with cancer undergoing catheter ablation for atrial fibrillation","volume":"25","author":"Agarwal S","unstructured":"Agarwal S, Munir MB, Krishan S, Yang EH, Barac A, Asad ZUA. Outcomes and readmissions in patients with cancer undergoing catheter ablation for atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2023 Aug 2;25(9):euad263.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"10","key":"e_1_3_3_108_2","article-title":"Outcome of atrial fibrillation ablation in cancer patients: A review","volume":"15","author":"Sharma NR","unstructured":"Sharma NR, Basnet A, Lamichhane S, et al. Outcome of atrial fibrillation ablation in cancer patients: A review. Cureus. 2023 Oct;15(10):e47818.","journal-title":"Cureus"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251408388","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296251408388","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251408388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:32Z","timestamp":1777385132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296251408388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":107,"alternative-id":["10.1177\/10760296251408388"],"URL":"https:\/\/doi.org\/10.1177\/10760296251408388","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"10760296251408388"}}